Biomarin Pharmaceutical (BMRN) Price to Earnings (2010 - 2026)
Biomarin Pharmaceutical's (BMRN) Price to Earnings stood at 151.76 in Q2 2026, up 845.0% from 16.06 a year earlier and up 273.6% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Price to Earnings (2010 - 2026) Analysis & Trends
For FY2025, Biomarin Pharmaceutical's Price to Earnings came in at 32.76, up 11.5% from FY2024.
- Across earlier years, Price to Earnings came in at 29.37 in FY2024 (-72.9%), 108.47 in FY2023 (-20.3%) and 136.16 in FY2022.
- The Q2 2026 figure is the highest quarterly Price to Earnings since Q2 2023.
- On a year-over-year basis, Price to Earnings has increased for three consecutive quarters, with growth averaging 73.0% over the last eight quarters.
- Peak year-over-year performance for Price to Earnings in the last five years was growth of 845.0% in Q2 2026, against a decline of 85.6% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 40.63 (Q1 2026), 32.76 (Q4 2025) and 19.99 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151.76 |
| Mar 31, 2026 | 40.63 |
| Dec 31, 2025 | 32.76 |
| Sep 30, 2025 | 19.99 |
| Jun 30, 2025 | 16.06 |
| Mar 31, 2025 | 25.87 |
| Dec 31, 2024 | 29.37 |
| Sep 30, 2024 | 41.56 |
| Jun 30, 2024 | 61.08 |
| Mar 31, 2024 | 80.68 |
| Dec 31, 2023 | 108.47 |
| Sep 30, 2023 | 113.35 |
| Jun 30, 2023 | 163.10 |
| Mar 31, 2023 | 254.73 |
| Dec 31, 2022 | 136.16 |
| Sep 30, 2022 | 187.72 |
| Jun 30, 2022 | 284.23 |
| Mar 31, 2022 | 362.31 |
| Sep 30, 2021 | 1,308.13 |
| Jun 30, 2021 | 18.38 |
API Access
Biomarin Pharmaceutical Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();